BiopharmaceuticalIndustry FellowshipProgram
2024-2026
Table of Contents
WelcometoPfizer
GlobalClinicalSupply(GCS)Overview
FellowshipLeadershipTeam
FellowshipProgramOverview
FellowshipObjectives
ClinicalResearchPharmacy
ClinicalSupplyStrategy&Management
ClinicalSupplyOperations
InnovativeSciencesOperations
GlobalClinicalSupplyFellows
FellowshipAlumniSpotlight
FellowshipAlumni
Networks&Associations
MCPHS
MCPHSFacultyAdvisors
MCPHSFellowsNetwork
ApplicationProcess
ApplicationTimeline
WelcometoPfizer
DearProspectivePfizerFellow,
ThankyouforyourinterestinthePfizerBiopharmaceuticalIndustryFellowshipPrograminpartnershipwith MCPHS.Asyouexploreourtwo-yearfellowshipprograminthefollowingpages,youwilldiscoverthemany uniqueopportunitiesthatenablefellowstotakepartinthejourneytodeliverlife-changingproducts.From clinicaltrialstomarketauthorization,PfizerfellowswillbeengagedinthekeyfunctionalareaswithinGlobal ClinicalSupply,suchasClinicalResearchPharmacy,ClinicalSupplyStrategy&Management,ClinicalSupply Operations,andInnovativeSciencesOperations.
Pfizer’slong-standinghistoryofleadershipandinnovationprovidesfellowswithunparalleledaccesstocuttingedgeclinicalresearchandindustry-leadingcolleagues,allwithacommonpurposeofprovidingbreakthroughs thatchangepatients’lives.Pfizerfellowshipalumnihaveaproventrackrecordofsuccessfullydeliveringonthis purposeandcontributingtoimpactfulprojects.Inturn,fellowshaveledfulfillingcareersbothatPfizerand withinthebiopharmaceuticalindustry.
OnbehalfofPfizerandMCPHS,IthankyouforyourinterestinthePfizerBiopharmaceuticalIndustry FellowshipProgramandwishyoutheverybestwithyourfellowshipselectionprocess.
Sincerely,
Michael Ku
MichaelT.Ku,PharmD,MBA VicePresidentandHeadofGlobalClinicalSupply PfizerResearchandDevelopmentExecutiveSponsor
Michael T. Ku, PharmD, MBA
Dr.KuistheVicePresidentandHeadofthe GlobalClinicalSupplyOrganizationwithin PfizerResearchandDevelopmentinGroton, CT.Dr.Kuhasover25yearsof biopharmaceuticalexperience,with20years intheareaofclinicalresearchandclinical supplies.HehasbeeninvolvedinthePfizer &MCPHSBiopharmaceuticalIndustry FellowshipProgramsinceitsinception.In 2020,heledthePfizerBioNTechCOVID-19 vaccineclinicalsupplychainteamstothe successfulEmergencyUseAuthorizationfor theworld’sfirstCOVID-19vaccine.Dr.Kuisa highlysought-afterspeaker,involvedina varietyofexternalcollaborationsandunique partnershipsspanningacrossthe biopharmaceuticallandscapeaswellas otherindustries.
PriortojoiningPfizer,heworkedatSanofi GenzymeCorporationinCambridge,MA.Dr. KucompletedtheGeneralManagement ProgramatHarvardBusinessSchooland receivedamaster’sdegreeinBusiness AdministrationfromAnnaMariaCollege.Dr. KuhasaPharmDandBachelorofSciencein PharmacyfromMCPHSandholdsa BachelorofScienceinToxicologyfromthe UniversityofToronto.
PfizerResearchandDevelopment
GlobalClinicalSupplyis...
Anorganizationthatsetstheclinicalsupplystrategy, systems,packaging,labeling,logisticsand managementofqualityinvestigationalproducts(IP) topatientsincompliancewithGoodManufacturing Practice(GMP)andGoodClinicalPractice(GCP) standardsforPfizer.
OurVision
TobethepremierGlobalClinicalSupplyorganization dedicatedtoprovidingquality,life-changing investigationalproductstopatients.
OurMission
o Promoteanagilelearningculturetoenablethe deliveryofqualityclinicalsuppliesand informationwithintegrity,compassion,and accountability
o Designclinicalsupplystrategiestoenable positivepatient-focusedexperiences
o Challengeourselvestoinnovateand continuouslyoptimizeourphysicalanddigital supplychains
o Collaboratewithinternalteamsandleverage strongexternalpartnershipstosupportthe developmentofmedicinesthatwininthe marketplace
o Manageanever-changingproductparadigm withcost-effectiveandtimelyclinicalsupply solutions
FellowshipLeadershipTeam
FellowshipDirector
Dr.WoodingisSeniorDirectoroftheGlobalClinicalSupply(GCS)Manila OperationshubandisbasedinAndover,MA.Dr.Woodinghasbeenwith Pfizerforover11yearsandhasover17yearsofcombinedpharmacy experienceinacademia,hospital,andambulatorycare.Priortojoining Pfizer,shewasanAssistantProfessorofPharmacyPracticeatMCPHS. Dr.WoodinghasaBachelorofScienceinHumanPhysiologyfrom BostonUniversityandcompletedaspecialtypharmacyresidencyin PrimaryCareattheProvidenceVeteransAffairsMedicalCenterafter receivingherPharmDfromMCPHSinWorcester,MA.
Fellowship
Mr.KayistheExecutiveDirectorofClinicalResearchPharmacywithinGlobal ClinicalSupplyatPfizer,Inc.basedinAndover,MA.PriortohisroleatPfizer, hewastheSeniorDirectorofClinicalPharmacyResearchServicesat GenzymeCorporation.Mr.Kayhasover20yearsofbiopharmaceutical industryexperienceintheareaofclinicalresearchspecializinginoncology, transplant,lysosomalstoragedisorders,andcardiovascularmedicine. Previously,Mr.KaywasaclinicalpharmacyspecialistatTuftsMedicalCenter inBostonandreceivedhispharmacydegreefromNortheasternUniversityin Boston,MA.
Executive Director, Clinical Research Pharmacy Fae Wooding, PharmD, RPh Senior Director, GCS Manila OperationsFellowshipAlumniAdvisor
BasedinAndover,MAwithinGlobalClinicalSupply,Dr.Schaulsohn joinedPfizerinJanuary2022.BeforejoiningPfizer,shewasaRare ProgramsLeadofGlobalMedicalAffairsRareDiseaseatChiesi,where sheledExpandedAccess,Investigator-InitiatedResearchandGrantsfor Chiesi'sGlobalRareDiseaseProducts.PriortoChiesi,Dr.Shaulsohnled multipleMedicalAffairsfunctionsatFlexionTherapeuticsandwas FellowshipDirectorfortheMedicalAffairspost-PharmDFellowship Program.Priortothatrole,shewasthesecondClinicalResearch PharmacistatPfizerforfiveyears,whereshealsocompleteda secondmentasanExpandedAccessLead.Shecompletedatwo-year MCPHSPost-DoctoralFellowshipatGenzymeinClinicalResearchfrom 2010-2012.Dr.ShaulsohngraduatedwithaDoctorofPharmacydegree fromNortheasternUniversityin2010.
FellowshipAcademicAdvisor
KelseySchaulsohn,PharmD,RPh Director,ClinicalResearchPharmacyBasedinToronto,OntariowithinGlobalClinicalSupply,Dr.Manhasbeen withPfizerforsevenyearsandhasover15yearsofclinicalpharmacy experienceworkingintheindustry,hospital,retail,andacademicsetting. PriortojoiningGCSClinicalResearchPharmacyTeam,hewastheField MedicalAdvisorforPfizerCanadaInternalMedicineBusinessUnitasa field-basedmedical/scientificexperttointernalandexternalstakeholders toinformmedical,research,andcommercialstrategiesandtactics.Dr. ManholdsaDoctorofPharmacyfromUniversityofTorontoand BachelorinPharmaceuticalSciencesfromUniversityofBritishColumbia.
DamenMan,PharmD,RPhFellowship Program Overview
PfizerInc.inconjunctionwithMCPHSoffersauniquetwo-yearpostPharmDfellowshipprograminGlobal ClinicalSupply(GCS).Thisfellowshipprogramprovidesacomprehensivepost-doctoralexperiencethat fostersprofessionalgrowthanddevelopsnecessaryskillsforasuccessfulcareerinthebiopharmaceutical industry.GlobalClinicalSupplyFellowsreceivein-depthtrainingineachofthecoreGCSfunctionallinesand participateinrotationalmodulesthroughoutotherdisciplineswithinthedrugdevelopmentprocess.
Recruiting:
3FellowsinGCSClinicalResearch Pharmacy
Location: Groton,Connecticut
FirstYear
FellowswillcompleteCoreCompetencyRotationsinthefollowingfunctionallines:
ClinicalResearch Pharmacy
ClinicalSupply Operations
ClinicalSupply Strategy& Management
InnovativeSciences Operations
Fellowswillalsohavetheopportunitytorotateinotherdisciplinesinvolvingthedrugdevelopmentprocess iftheywouldlikeadditionalexperiencesaftercompletionoftheircorerotations.
SecondYear
Fellowswillapplytheirlearningsfromthefunctionallinestheyrotatedthroughduringtheirfirstyearto immersethemselvesandtakeresponsibilityforprojectswithinClinicalResearchPharmacy.The experiencesgainedovertheirsecondyearwilldeepentheirknowledgeregardingtheclinicaldevelopment processandtheirskillsasapharmacistwithinindustry.
Fellowship Objectives
Gainin-depth experienceacross multiplefacetsofthe drugdevelopment process
Develop, coordinate,and delivervarious DiseaseState Overviewsand ClinicalPatient Journeys Enhanceproject management, communication, andleadership skills
Createsite/patient focusedtoolsand trainingfor investigational products
Understandthe processof manufacturing, packaging,labeling, anddistributionof investigational products
UtilizeInteractive Response Technologyto optimizeclinical trialoperations Collaboratewith cross-functional teamstodevelop andexecuteclinical supplystrategy
ClinicalResearch Pharmacy
TheClinicalResearchPharmacy(CRP)rotationwillprovide clinicalpharmacyexpertisetooptimizethepreparationand administrationofInvestigationalProducts(IP)throughthe developmentofsupportingdocumentsandtrainingfor clinicalsites.
ProgramCoordinator
LucieLaJeunesse,RPh Director,ClinicalResearchPharmacyBased in Groton, CT within Global Clinical Supply, Ms. LaJeunesse has been with Pfizer for nine years and has over 30 years of pharmaceutical experience in hospital, Investigational Drug Services, and Remote Order Entry. Prior to joining Pfizer, Ms. LaJeunesse was an Investigational Drug Pharmacist at UMASS Memorial Medical Center in Worcester, MA and a clinical pharmacist in remote order entry at Cardinal Health where she maintained pharmacy licensure in 11 states. In December of 2021, she completed the Supply Chain Management Leadership Academy at University of Tennessee, Knoxville. Ms.LaJeunesseearnedherpharmacydegreefromMCPHS inBoston,MA.
Developan understandingof diseasestate,study designandprotocol requirementsto identifyappropriate patient-focusedtools
Utilizepharmacy expertisein providing consultationto clinicalteamsand sitesformedicationrelatedissues
Partnerwithclinical sitesandGlobal Product Developmentto optimizeclinicaltrial conduct
Developsiteand patientcentric investigational productpreparation andadministration instructions andtraining
Influenceprotocol andproduct developmentto ensureclinical suppliesare designedwithpatient focusandquality
ClinicalSupplyStrategy &Management
TheClinicalSupplyStrategyandManagement(CSSM)rotation willfocusondevelopinganeffectivestrategyformanaging investigationalproductsinglobalclinicaltrialsfromfirst-inhumanstudiesthroughcommercializationbyexceedingthe expectationsofcustomers,consumersandclinicalsites.
Translateclinical objectivesintosupply forecastscenarios andmanage executionbyGCS functionallines
ProgramCoordinator
JenniferBulthuis,PharmD,RPh Director,ClinicalSupplyStrategy& ManagementGroupLeadIntegrateproject managementskills withincross-functional teamstomeetdynamic clinicaltrialtimelines
Utilizereal-time clinicaltrial enrollmentand inventorydatato ensuresupply continuitythroughout theclinicaltrial lifecycle
Dr.BulthuishasbeenwithPfizerformorethan20yearsas a Supply Chain Project Manager. She has supported all phases of investigational developments to coordinate and drive the clinical supply process by forecasting, managing, and delivering worldwide investigational drug supplies. In 2020, she moved to the Group Lead role, where she is responsible for the end-to-end oversight of clinical supply chainactivity.Priortoherindustryexperience,sheworked as a part-time retail pharmacist and a clinical/staff pharmacist. Dr. Bulthuis received her PharmD from the University of Michigan and completed a 1-year pharmacy residencyatWilliamBeaumontHospital.
ClinicalSupply Operations
TheClinicalSupplyOperations(CSO)rotationwillprovide theoversightofthecriticalactivitiesassociatedwiththe packaging,labeling,anddistributionofinvestigational productstotheclinicalsites.
ProgramCoordinator
CarolRose,BS,MS,MBA SeniorDirector,ClinicalSupplyOperationsApplyGood Manufacturing Practices(GMP)to clinicalsuppliesused inglobalPhaseI-IV clinicaltrialsand investigatorinitiated studies
Operatewithina labelingteamfocused onpatientclinicallabels usingglobalregulatory requirements
Utilizeinventory managementand distributionlogisticsto facilitatereal-time clinicalsupplyallocation
BasedinGroton,CTwithinGlobalClinicalSupply,Ms. Rose has been with Pfizer for more than 30 yearsdedicated to project advancement in Medicinal Sciences. In Clinical Supply Operations, she and her team focus on clinical supply packaging, labeling, and logistics solutions to deliver patient focused clinical supply strategies for Pfizer global clinical studies. Her Pfizer career history includes innovative business solution implementation in chemical sourcing,knowledgemanagement,businessmanagement, laboratory research for formulation and synthetic process development, technology transfer for manufacture, and registration principles for new medicines. Ms. Rose earned her Bachelor of Arts and Sciences degree in mathematics and chemistry from Salve Regina University, her Master of Science degree in management from Albertus Magnus College, and her Master of Business Administration from QuinnipiacUniversity.
Participateinbusiness reviewstoevaluate theadvantagesand disadvantagesof variousclinicalsupply models
Understandthe interfacebetween disparateinternal andexternalsystems andtheirintegration intotheGCSfunction
InnovativeSciences Operations
TheInnovativeSciencesOperations(ISO)rotationprovides experiencesindigitalclinicalsupplychainsystemssuchas InteractiveResponseTechnologies(IRT)thatenablePfizerto conductclinicaltrialsgloballywithoperationalexcellence.
Utilizeaclinicaltrial IRTtestsystemto understandthesite userexperience andconsiderations thatimpactIRT design
ProgramCoordinator
BrianFulling,PharmD,RPh Director,IRTSupportGroupLeadOptimizedaily businessoperations acrossourglobal footprintbyusing datavisualizationtools tomakeinformed decisions
Engagewithglobal ISOcolleaguesto learnaboutregional practicesthatmay affecttheconductof aclinicaltrial
Based in Groton, CT within Global Clinical Supply, Dr. Fulling is a Director of the Interactive Response Technology (IRT Support Team, part of the Innovative Sciences Operations group. He is responsible for ensuring 24/7 support for the Pfizer IRT system (Impala) which is integral for enrollment and drug assignment activities in over 120 Pfizer studies. Dr. Fulling has held various roles in the industry over the past 15 years ranging from Supply Management, Clinical Research Pharmacy, and Logistics to experience as a Medical Science Liaison. Prior to his industry experience, he worked as an Oncology Pharmacist and Investigational Drug Services Pharmacist at Methodist Hospital in San Antonio, Texas. Dr. Fulling received his Bachelor of Science in Pharmaceutical SciencesandPharmDfromtheUniversityofToledo,OH.
GlobalClinicalSupplyFellows
CurrentFellows
SecondYearFellows
AngelLiuisoriginallyfromStatenIsland,NewYork Angelreceivedher DoctorofPharmacyfromtheUniversityofBuffaloSchoolofPharmacy andPharmaceuticalSciencesinNewYork.ShewastheVicePresidentof theStudentNationalPharmaceuticalAssociationBuffaloChapterand washeavilyinvolvedinservingtheunderservedviacommunityprojects. Whileinschool,AngelworkedasaResearchAssistantandsupportedan NIH-fundedproject.Thisexperiencehelpedherdevelopastrong backgroundinprotocoldevelopmentandclinicaldataevaluation Furthermore,AngelservedasaclinicalcontractorwithAntidote TechnologyinNewYork,NY.DuringAngel’ssparetime,sheenjoys spendingtimewithfamilyandfriendsandstaysactivebygoingtothe gymandhiking
AliNaraghireceivedhisDoctorofPharmacyfromthe UniversityofIowainIowaCity,Iowa.Duringpharmacyschool hewasinvolvedinmultipleleadershippositions,including beingaRegionalLiaisonforPhiLambdaSigma.Healso helpedestablishtheIndustryPharmacistsOrganization studentchapterattheUniversityofIowa.Hewasaninternat theUniversityofIowaHospitalsandClinicsforoverfiveyears workinginIVAdmixturesandtheCentralDispensing Pharmacy.Inhissparetime,Alienjoysstayingcompetitive playingsports.HeisalsoahugefanoftheDallasareasports teamsandtheIowaHawkeyes.
UrviPatelisfromNashville,Tennessee.ShereceivedherDoctorof PharmacyandMaster’sinHealthInformaticsfromtheUniversityof TennesseeHealthScienceCenter.Whileinschool,sheservedonthe executiveboardoftheRhoChiHonorSociety,completedaLeadership ExplorationandAbilityDevelopmentprogram,andreceivedherGreen BeltinLeanSixSigma.Shealsohadsixyearsofcommunitypharmacy experienceandhasstronginterestsintheareasofoncology/ hematologyresearch,qualityimprovement,andprojectmanagement. Duringhersparetime,sheenjoysreadingandplanningoutdoor adventures.Shelovestotravelandvisitnewcountries,aswellas spendmeaningfultimewithfamilyandfriends.
AliNaraghi,PharmD CSSMFellowFirstYearFellows
AnnaLiuisfromWestHartford,ConnecticutandreceivedherDoctor ofPharmacyfromUniversityofConnecticutinStorrs,Connecticut. Duringpharmacyschool,Annawasheavilyinvolvedinresearchand servedinleadershippositionsfororganizationswiththegoalto advancethepharmacyprofession.ShewasthePresidentofthe StudentSocietyofHealth-SystemPharmacistsandCommunications VicePresidentoftheAmericanPharmacistsAssociation.Annaworked inacommunitypharmacythroughoutschoolandhasinterestsina broadrangeofdiseasestates.Annaenjoysspendingtimewithher lovedones,exploringrestaurants,andhiking
JesseMadoreisfromSalem,NewHampshire.Shereceivedher DoctorofPharmacyfromMassachusettsCollegeofPharmacyand HealthSciencesinBoston,Massachusetts.Duringpharmacyschool, shewasanactivememberofAmericanPharmacistsAssociation AcademyofStudentPharmacistsandPharmacyCouncil.Shehas fouryearsofcommunitypharmacyexperienceandhasstrong interestsinacademiaandoncologyresearch.Duringherspare time,Jesseenjoyswritingpoetryandspendingtimewithhercat, October.ShealsolovessnowboardinginNewHampshire.
LeahPottsgrewupinGering,Nebraska.ShereceivedherDoctorof PharmacyandMaster'sinTranslationalPharmacologyfromtheOhio StateUniversityCollegeofPharmacyinColumbus,Ohio.Whilein pharmacyschool,shewasamemberofthelocalIndustry PharmacistsOrganizationandtheAmericanSocietyofConsultant Pharmacistsandengagedinoutreacheventstobringcareto underservedpopulations.Leahalsohasfiveyearsofexperiencein communitypharmacyandhasinterestsintheresearchareasof neurology,vaccines,andrarediseases.Inherfreetime,Leahlovesto hike,traveltonewplaces,paint,andtryoutanyrecipethatstrikes herfancy.
AnnaLiu,PharmD CRPFellow JesseMadore,PharmD CRPFellow LeahPotts,PharmD CRPFellowFellowship AlumniSpotlight
"Theunmatchedmentorshipandvariousopportunities providedtomeduringthefellowshipprogramallowedfora seamlesstransitionintomycurrentrole.Thefirstrotational yearallowedmetolearnaboutPfizer'sGlobalClinical SupplyOrganizationandhowdifferentdepartments collaborateandinteractwithoneanother.Thesecondyear allowedmetolearnmycurrentroleandbuildlasting relationshipswithcolleagueswithinGCS&VendorQuality Operations."
"ThePfizerFellowshipprogramprovidedmewithexposure tothevariousroleswithinGlobalClinicalSupply,lendingto exceptionallearningopportunitiesandskillsthatcanbe leveragedinmycareerahead.AlthoughtheFellowship programprovidednumerousbenefits,Ifoundthe establishmentofaprofessionalnetworkthatfostersan innovativeculturetobeextremelyrewarding.Thisnetwork providesmewithimmensesupportandhasbeenpivotalto mycareergrowthinthepharmaceuticalindustry."
EmilyZatakia Fellow"Thefellowshipprogramprovidesbroadexposuretodrug development,frommoleculetopatientuseinclinicaltrials. Theopportunitytocontributetodevelopingtreatmentsfor incurablediseaseshasdrivenmetopushboundaries,find novelsolutions,andutilizemypharmacybackgroundto impactpatientsofthefuture."
SeniorManager-ClinicalSupplyChainLeadFellowship Alumni
JonathanHui,PharmD, RPh
CSSMFellow2021–2023 Manager-GlobalClinical SupplyChain
Takeda
CrystalMa,PharmD, RPh
CSSMFellow2019-2021 SeniorManager-Global ClinicalSupply
Alexion Pharmaceuticals,Inc.
JankhnaYadav,MD, PharmD
CSSMFellow2018-2020 Director-FieldMedical, RareCardiology Pfizer,Inc.
AnhNguyen,PharmD, RPh
QAFellow2016-2018 SeniorManager-Medical Information
Biogen
EkaterinaEfimova, PharmD,RPh
CRPFellow2015-2017 AssociateDirector-Global ScientificCommunications
VertexPharmaceuticals
NathanLamore,PharmD, RPh
CSSMFellow2020-2022 Manager-ClinicalSupply Chain
EliLilly&Co.
KellyChan,PharmD,RPh
CRPFellow2018-2020 SeniorManager-Medical Information
AstraZeneca WilhelminaLord-Adem, PharmD,RPh
CSSMFellow2017-2019 FieldMedicalScientist
Bristol-MyersSquibb
EmilyZatakia,PharmD, RPh
CSSMFellow2016-2018 SeniorManager-Clinical SupplyChainLead Pfizer,Inc.
AdamCraig,PharmD, RPh
CSSMFellow2014-2016 SeniorManager-Clinical SupplyChainLead Pfizer,Inc.
ZacharyKogut,PharmD, RPh
CSSMFellow2019-2021 Manager-ClinicalSupply Chain
Agios
HarjotOthee,PharmD, RPh
QAFellow2018-2020 Manager-QualityAssurance Pfizer,Inc.
BrianHoward,PharmD, RPh
CRPFellow2016-2018 AssociateDirector-Clinical SupplyQuality
Alexion Pharmaceuticals,Inc.
AakashDheri,PharmD, RPh
CSSMFellow2015-2017 MedicalScienceLiaison Allergan
JacobMattox,PharmD, RPh
QAFellow2014-2016 AssociateDirector-US FieldMedicalTraining, Immunology
Sanofi
JohnO'Brien,PharmD, RPh
CSSMFellow2013-2015 SeniorManager-Clinical Supply&Logistics
Beigene
LuzShepherd,PhD, PharmD,RPh
CSSMFellow2013-2015 Director-ClinicalSupply Chain
DecipheraPharmaceuticals
JaclynnNg,PharmD, RPh
CSSMFellow2012-2014 ProgramDirectorRegulatoryAdvertising& Promotions
Genentech
PfizerPharmacyFellowshipNetwork
Charteredin2014,thePfizerPharmacyFellowshipNetwork(PPFN)seekstobuildastrongalumninetwork offellowswithinPfizeracrossdifferentprograms,connectingbothcurrentandpastfellows.ThePPFN engageswithfellowstotakegreaterinitiativeswithinthecompanyinordertocontributetotheindustryand establishastrongfoundationofmentorship.
PfizerPharmacistsAssociation
Inauguratedin2015,thePfizerPharmacistsAssociation’s(PPA)missionistoleveragetheunique perspectiveandskillsetsofpharmacistswiththepurposeofachievingPfizer’soverallvisiontodeliver breakthroughsthatchangepatients’lives.ThePPAprovidesopportunitiesforpharmacyprofessionalsto engageinactivitiesfocusedonoptimizingpharmacistlearningexperiencesandcapitalizingonthetalent pooltobringvalueinthePfizerbusiness.
MCPHS
MCPHSprovidesanacademicenvironmenttoguideand supportthefellowstowardasuccessfulcareerinthe biopharmaceuticalindustry.Asaprivateinstitutionwith ahistoryofspecializationinhealthsciences,MCPHS offersprogramsthatembodyscholarship, professionalservice,andcommunityoutreach. ThroughMCPHS,thefellowwillhavethe opportunitytogainteachingandresearch experienceinanacademicsetting.
MCPHSfacultyandcompany programleadersmentor fellowsaccordingtotheir scholarlyandprofessional intereststhroughoutthe two-yearprogram.
AsanadjunctassistantprofessoratMCPHS,thefellowwillhavetheopportunityto:
•Develop,coordinate,andteachcoursesattheBoston,Worcester,orManchestercampus
•Co-preceptstudentsonadvancedexperientialrotations
•Createandpublishscholarlyresearchand/orreviewarticles
•Presentresearchatscientificandclinicalmeetings
•Participateinprofessionaldevelopmentseminarswithfellowsandresidents
MCPHS Faculty Advisors
AmeeMistry,PharmD,RPh DirectorofFellowshipProgram
Dr.AmeeMistryisProfessorofPharmacyPracticeandhasbeenwithMCPHSsince2006. Dr.MistryearnedherPharmDattheAlbanyCollegeofPharmacyandcompletedaPGY1 CommunityPracticeResidencywithWalgreensandMCPHS.In2015,Dr.Mistrytookoveras DirectoroftheMCPHSBiopharmaceuticalIndustryFellowshipprogram.Sheworksdirectlywith leadersintheareatocontinuetofostergrowthanddevelopmentofthepostgraduateprogram andtoassistthefellowsinattainingpositionswithinthepharmaceuticalindustry.Inaddition, sheisadvisorforthestudentIPhOchapteratMCPHS,co-advisorforAPhA-ASP,anationaltrainer fortheAPhAPharmacy-BasedImmunizationtrainingprogramandisactivelyinvolvedwiththe MassachusettsPharmacistsAssociation.
PaulBelliveau,PharmD,RPh FacultyPreceptor
Dr.BelliveauearnedhisBachelorofScienceinPharmacyfromtheUniversityofRhodeIsland in1988andhisPharmDfromMCPHS-Bostonin1991.HecompletedanAntibioticManagement FellowshipatHartfordHospitalinHartford,CTin1993.Dr.BelliveauiscurrentlyProfessorandDean atMCPHSSchoolofPharmacy-Worcester/Manchester Dr Belliveau’sareasofinterestinclude infectiousdiseases,pharmacokinetics,academicleadership,andpharmacyeducation.
JenniferTowle,PharmD,RPh FacultyPreceptor
Dr.TowleearnedherBachelor’sdegreeinCellular,Molecular,andDevelopmentalBiology fromtheUniversityofNewHampshirein2007andherPharmDfromMCPHS-Worcester/ Manchesterin2012.Shecompletedherpost-graduateyearone(PGY-1)atElliotHealth-Systemin Manchester,NHin2013.Dr.TowleisanAssociateProfessorofPharmacyPracticeatMCPHSWorcester/Manchester.Herareasofinterestincludeeducation,pediatrics,transitionsofcare, andmedicationsafety.
JasonCross,PharmD,BCPS,BCACP,RPh FacultyPreceptor
Dr.CrossearnedhisPharmDfromtheUniversityofRhodeIslandin2001andcompleted anASHPPGY1PharmacyResidencyin2002atUMassMemorialMedicalCenter.Dr.Crossis currentlyanAssociateProfessorofPharmacyPracticeatMCPHS-Worcester/Manchesterand theResidencyProgramDirectorofthePGY1CommunityPharmacyResidencyatBaystate MedicalCenter.Dr.Cross’sareasofinterestincludepharmacyeducation,acuteandchronicheart failure,impactofpharmacystudentsonclinicalservicesandexpansionofpharmacyservicesin ambulatorycare.
MCPHSFellowsNetwork
Aspartofthefellowshipprogram,theMCPHSFellowsNetwork(MFN)fostersacommunityofpharmacists workingwithinthepharmaceuticalindustry.Thenetworkconnectsbothcurrentfellowsandprogram alumnithroughprofessionaldevelopment,scholarship,andservice.AllMCPHSfellowsmeetregularlyin Bostonwhenattendingconferenceseriesandprofessionaldevelopmentdays.Additionally,fellowsare invitedtoparticipateinavarietyofMFNsocialandcommunityeventsandtheNewEnglandPharmacy TeachingandLearningSeminar.TheMFNconnectsfellowsfromthefollowingpharmaceuticalcompanies:
Application Process
Step 1: Eligibility
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
• Candidatesmusthavestrongwrittenandverbal communicationskillsandastronginterestinpursuing acareerwithinthebiopharmaceuticalindustry.
• Allcandidatesmusthaveauthorizationtoworkin theUnitedStatesthroughoutthedurationofthe two-yearfellowship.Novisasponsorshipwillbe provided(i.e.,TN,H-1B,etc.)
• Fellowsarerequiredtoobtainpharmacylicensure withinthefirst6monthsofthefellowshipand maintainitthroughoutthedurationoftheprogram.
Step2:Application
TheMCPHSapplicationportal(SMApply)willopenon Monday,October2nd,2023.Applicantsmustupload thefollowingapplicationmaterialstotheonlineportal (https://mcphs.smapply.io)nolaterthanFriday, November17th,2023:
• LetterofIntent
• CurriculumVitae(CV)
• Unofficialcollegetranscript
• ContactinformationforthreereferencesReferenceswillreceiveanelectronic recommendationformtocompleteseparately. Threerecommendationevaluationformsmust besubmittednolaterthanMonday,November 27th ,2023,viatheonlineportal.ThisisNOTa letterofrecommendationbutanonlineformthat therecommenderwillreceiveforcompletion fromSMApply.
Step3:RollingApplicationReview&Interviews
Allsubmittedapplicationswillbereviewedona rollingbasis.Interviewswillalsobeofferedona rollingbasisandopportunitiesarelimited.Priority willbegiventothoseapplicantswhoapplyearly,well inadvanceofthedeadline.
Rollinginterviewswillstartmid-Octoberwithprescreensandamixtureofinterviewroundswhich willconcludeinDecemberattheendoftheASHP MidyearClinicalMeeting.Candidateswillbenotified ifselectedforaninterview.
Step4:ASHPMidyear&On-siteInterviews
ThefellowshipprogramwillbeconductinginpersoninterviewsattheASHPMidyearClinical MeetinginAnaheim,CA.Applicantsarestrongly encouragedtoattend.Candidatesattending in-personwillnotbeabletointerviewwithout registeringforbothASHPandPPS.Pleasereferto theASHP&PPSwebsiteforregistrationdetails. Topcandidatesmaybeinvitedforinterviewsatthe sponsoringcompany’slocation.
Step5:OfferDates
RecognizingthatthechoiceofaPost-Doctoral IndustryFellowshipisanimportantdecision,MCPHS inconjunctionwiththeAcademicIndustry FellowshipAlliance(AIFA),hasagreedtoextend offersforFellowshipsnoearlierthanWednesday, December13th,2023.
Step6:Onboarding
Finalcandidateswillberequiredtogothrough additionalscreening/onboardingas requiredbyMCPHS.
2023ApplicationTimeline
September 24
October 2
October Mid
November 17
MCPHS Industry Fellowship Day (virtual)
Survey Monkey Apply Portal opens for applications
Rolling interviews begin
Applicationdeadline
November 27
December 3-7
Deadline for recommendation forms
December 13
Interviewsat2023ASHPMidyearinAnaheim,CA
Fellowship offers begin
558 Eastern Point Road
Groton, CT 06340 PharmDFellowships@pfizer.com